UC Irvine

Corneal afflictions are the second leading cause of blindness worldwide. When a corneal transplant is unavailable or contraindicated, an artificial cornea device is the only chance to save sight. Bacterial or fungal biofilm build up on artificial cornea devices can lead to serious complications including the need for systemic antibiotic treatment and even explantation. As a result, much emphasis has been placed on anti-adhesion chemical coatings and antibiotic leeching coatings. These methods are not long-lasting, and microorganisms can eventually circumvent these measures. Thus, I have developed a surface topographical antimicrobial coating. Various surface structures including rough surfaces, superhydrophobic surfaces, and the natural surfaces of insects’ wings and sharks’ skin are promising anti-biofilm candidates, however none meet the criteria necessary for implementation on the surface of an artificial cornea device.

In this thesis I: 1) developed scalable fabrication protocols for a library of biomimetic nanostructure polymer surfaces 2) assessed the potential these for poly(methyl methacrylate) nanopillars to kill or prevent formation of biofilm by E. coli bacteria and species of Pseudomonas and Staphylococcus bacteria and improved upon a proposed mechanism for the rupture of Gram-negative bacterial cell walls 3) developed a scalable, commercially viable method for producing antibacterial nanopillars on a curved, PMMA artificial cornea device and 4) developed scalable fabrication protocols for implantation of antibacterial nanopatterned surfaces on the surfaces of thermoplastic polyurethane materials, commonly used in catheter tubings. This project constitutes a first step towards fabrication of the first entirely PMMA artificial cornea device.

The major finding of this work is that by precisely controlling the topography of a polymer surface at the nano-scale, we can kill adherent bacteria and prevent biofilm formation of certain pathogenic bacteria, without the use of any chemical antibiotic agents. Such nanotopographic coatings can be applied to implantable polymer medical devices with scalable, commercializable processes, and may deter or delay biofilm formation, potentially improving patient outcomes. This thesis also opens the door for adaptation of antibacterial, nanopillared surfaces for other applications including other medical devices, marine applications and environmental surfaces.